Evidence map›Paper›PMID 33836078›Full record

ArticleNucleic acids research2021

Suppression of liquid-liquid phase separation by 1,6-hexanediol partially compromises the 3D genome organization in living cells.

Sergey V Ulianov, Artem K Velichko, Mikhail D Magnitov, Artem V Luzhin, Arkadiy K Golov, Natalia Ovsyannikova, Igor I Kireev, Alexey S Gavrikov, Alexander S Mishin, Azat K Garaev and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phase separation of DDHD2 remodels lipid metabolism to dictate treatment sensitivity in luminal breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Dual targeting of AMRC12 andTheranostics · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Sergey V UlianovInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.ORCID 0000-0002-6187-310X
Artem K VelichkoInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.
Mikhail D MagnitovInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.
Artem V LuzhinInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.
Arkadiy K GolovInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.
Natalia OvsyannikovaA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
Igor I KireevA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia.
Alexey S GavrikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Alexander S MishinShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Azat K GaraevInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.ORCID 0000-0002-8460-173X
Alexander V TyakhtInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.ORCID 0000-0002-7358-2537
Alexey A GavrilovInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.
Omar L KantidzeInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.ORCID 0000-0002-7507-7307
Sergey V RazinInstitute of Gene Biology Russian Academy of Science, 119334 Moscow, Russia.ORCID 0000-0003-1976-8661
Institute of Gene Biology · RULomonosov Moscow State University · RUInstitute of Bioorganic Chemistry · RUMoscow Institute of Physics and Technology · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid-liquid phase separation (LLPS) contributes to the spatial and functional segregation of molecular processes within the cell nucleus. However, the role played by LLPS in chromatin folding in living cells remains unclear. Here, using stochastic optical reconstruction microscopy (STORM) and Hi-C techniques, we studied the effects of 1,6-hexanediol (1,6-HD)-mediated LLPS disruption/modulation on higher-order chromatin organization in living cells. We found that 1,6-HD treatment caused the enlargement of nucleosome clutches and their more uniform distribution in the nuclear space. At a megabase-scale, chromatin underwent moderate but irreversible perturbations that resulted in the partial mixing of A and B compartments. The removal of 1,6-HD from the culture medium did not allow chromatin to acquire initial configurations, and resulted in more compact repressed chromatin than in untreated cells. 1,6-HD treatment also weakened enhancer-promoter interactions and TAD insulation but did not considerably affect CTCF-dependent loops. Our results suggest that 1,6-HD-sensitive LLPS plays a limited role in chromatin spatial organization by constraining its folding patterns and facilitating compartmentalization at different levels.

Indexed as

ChromatinEnhancer Elements, GeneticGenome, HumanGlycolsHeLa CellsHumansMicroscopyPromoter Regions, GeneticChromatinGlycolshexamethylene glycol

Identifiers

PMID33836078
PMCPMC8501969
OpenAlexW3150768399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.